Update on Legal Claims

By

Regulatory News | 18 Jul, 2024

Updated : 07:01

RNS Number : 8399W
Versarien PLC
18 July 2024
 

18 July 2024

Versarien plc

("Versarien" or the "Company")

Update on Legal Claims

Further to its announcement dated 7 February 2024, Versarien plc (AIM: VRS), the advanced materials engineering group, has received correspondence from the Employment Tribunal that owing to a lack of judicial resources, the preliminary hearing for case management scheduled for 17 July 2024 has been postponed and will be re-listed for the next available date.

As stated in the Company's Annual Report 2023, due to the early stages and legal advice received around expected outcomes, it has been agreed that no provision for any liability is required regarding this legal claim.

Further announcements will be made following the outcome of the preliminary hearing for case management.

For further information please contact:

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a manufacturing-light and licensing model.

 

For further information please see: http://www.versarien.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDVDLFFZDLLBBQ

Last news